ZFYVE21 Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA534408-Each-of-1 | In Stock | ₹ 47,392.50 |
PIPA534408 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 47,392.50
GST (18%): ₹ 8,530.65
Total Price: ₹ 55,923.15
Antigen
ZFYVE21
Classification
Polyclonal
Conjugate
Unconjugated
Gene
ZFYVE21
Gene Alias
1110013H04Rik; AW558780; C85416; FYVE domain containing 21; HCV p7-transactivated protein 1; HCVP7TP1; ZF21; Zfyve21; Zinc finger FYVE domain-containing protein 21; zinc finger FYVE-type containing 21; zinc finger, FYVE domain containing 21
Host Species
Rabbit
Purification Method
Antigen affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
362789, 68520, 79038
Content And Storage
Maintain refrigerated at 2-8°C for up to 3 months. For long term storage store at -20°C
Form
Liquid
Applications
Immunohistochemistry, Western Blot
Concentration
1 mg/mL
Formulation
PBS with 0.02% sodium azide
Gene Accession No.
D3ZVP7, Q8VCM3, Q9BQ24
Gene Symbols
ZFYVE21
Immunogen
A 15 amino acid synthetic peptide near the amino terminus of human ZF21
Quantity
100 μg
Primary or Secondary
Primary
Target Species
Human, Mouse, Rat
Product Type
Antibody
Isotype
IgG
Related Products
Description
- A suggested positive control is NIH-3T3 cell lysate
- PA5-34408 can be used with blocking peptide PEP-1450
- ZF21 was initially identified as protein that could bind to the cytoplasmic tail of MT1-MMP (Membrane-type 1 matrix metalloproteinase), a potent invasion-promoting protease
- ZF21 is a member of a protein family characterized by the presence of a phosphatidylinositol 3-phosphate-binding FYVE domain and regulates focal adhesions (FAs) and cell movement
- Knockdown of ZF21 expression resulted in a delay of FA disassembly following induction of synchronous disassembly of FAs by nocodazole treatment, suggesting that ZF21 is involved in FA disassembly
- ZF21 contains a noncanonical pleckstrin homology domain that is a possible therapeutic target to treat metastatic cancer.